医学理论与实践
醫學理論與實踐
의학이론여실천
The Journal of Medical Theory and Practice
2014年
19期
2521-2522
,共2页
卢金华%夏敏%戴清月%程熙%赖靖慧
盧金華%夏敏%戴清月%程熙%賴靖慧
로금화%하민%대청월%정희%뢰정혜
脑卒中%痉挛%上肢%A型肉毒毒素
腦卒中%痙攣%上肢%A型肉毒毒素
뇌졸중%경련%상지%A형육독독소
Stroke%Spasticity%Upper limbs%Botulinum toxin A
目的:探讨局部注射A型肉毒毒素(BTX-A)对脑卒中后痉挛性肘及手功能障碍的改善作用。方法:20例伴有上肢痉挛的患者在BTX-A 治疗前及治疗后2周、4周和12周应用改良 Ashworth量表(MAS)、Fugl-Meyer量表(FMA)、改良Barthel指数(MBI)进行评估。结果:治疗后MAS改善(P<0.05),改善于注射后2周稳定出现,并至少维持12周。FMA、MBI与治疗前比较无显著性差异(P>0.05)。结论:BTX-A局部注射可以改善脑卒中后上肢痉挛及部分功能。
目的:探討跼部註射A型肉毒毒素(BTX-A)對腦卒中後痙攣性肘及手功能障礙的改善作用。方法:20例伴有上肢痙攣的患者在BTX-A 治療前及治療後2週、4週和12週應用改良 Ashworth量錶(MAS)、Fugl-Meyer量錶(FMA)、改良Barthel指數(MBI)進行評估。結果:治療後MAS改善(P<0.05),改善于註射後2週穩定齣現,併至少維持12週。FMA、MBI與治療前比較無顯著性差異(P>0.05)。結論:BTX-A跼部註射可以改善腦卒中後上肢痙攣及部分功能。
목적:탐토국부주사A형육독독소(BTX-A)대뇌졸중후경련성주급수공능장애적개선작용。방법:20례반유상지경련적환자재BTX-A 치료전급치료후2주、4주화12주응용개량 Ashworth량표(MAS)、Fugl-Meyer량표(FMA)、개량Barthel지수(MBI)진행평고。결과:치료후MAS개선(P<0.05),개선우주사후2주은정출현,병지소유지12주。FMA、MBI여치료전비교무현저성차이(P>0.05)。결론:BTX-A국부주사가이개선뇌졸중후상지경련급부분공능。
Objective:To evaluate the efficacy of botulinum toxin type A (BTX-A) in the treatment of upper limb mus-cle spasticity ,especially hand function obstacle and elbow extension ,caused by stroke .Methods:Muscle tone was as-sessed using the Modified Ashworth Scale (MAS) .Other outcome measures were the Fugl-Meyer assessment(FMA) and modified Barthel lndex(MBI) .20 patients were assessed at baseline and 2 ,4 and 12 weeks after treatment .Results:The scores of MAS improved after treatment(P<0 .05) ,from 2 weeks to 12 weeks .No significant improvement was observed in FMA and MBI(P>0 .05) .Conclusion:Local BTX-A injection can reduce the spasticity ,and improve func-tion of upper limbs for stroke patients .